Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04721717 · ClinicalTrials.gov registry record
AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis
A clinical trial of Multiple Sclerosis and Spinal Cord Injuries, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- 160
- Enrollment target
- 1
- Study location
NCT04721717 is a study of Multiple Sclerosis and Spinal Cord Injuries that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 160 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04721717, a study of Multiple Sclerosis and Spinal Cord Injuries, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
The UAB Institute for Arts In Medicine (AIM) is currently implementing an expressive emotional writing pilot project for adults with paralysis caused by neurological conditions such as traumatic head or spinal cord injury.
Conditions Studied
Study Locations (1)
Alabama
- 354 School of Health Professions Building - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2027-03-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04721717
The ClinicalTrials.gov registry entry for NCT04721717 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (73% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.
NCT04721717 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT04721717 about?
NCT04721717 is a clinical study titled "AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis". The UAB Institute for Arts In Medicine (AIM) is currently implementing an expressive emotional writing pilot project for adults with paralysis caused by neurological conditions such as traumatic head or spinal cord injury.
What is the current status of trial NCT04721717?
This trial is currently recruiting. The enrollment target is 160 participants. The study started on 2020-09-01. Estimated completion is 2027-03-28.
What conditions does trial NCT04721717 study?
This clinical trial studies the following conditions: Multiple Sclerosis, Spinal Cord Injuries, Amyotrophic Lateral Sclerosis, Transverse Myelitis.
Who is sponsoring clinical trial NCT04721717?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04721717 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Vancomycin Study in Multiple Sclerosis (MS)
RECRUITING · Phase 1
-
IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis
RECRUITING
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.